Navigation Links
Blue Cross Promotes Two Leaders in Public Affairs
Date:3/3/2008

he Minnesota Comprehensive Health Association, the Minnesota Council of Health Plans, the Blue Cross and Blue Shield of Minnesota Foundation, and the Alliance for Advancing Nonprofit Health Care. She also served as a 2004-2005 policy fellow with the Humphrey Institute Policy Forum. Mock is a graduate of the William Mitchell College of Law in St. Paul and the College of St. Benedict in St. Joseph, Minnesota.

About Philip Stalboerger

Stalboerger has advocated public policy positions for Blue Cross since joining the organization 1999. Prior to Blue Cross, Phil was the legislative director at the Minnesota Department of Commerce. He has also served as staff in the Minnesota Senate, including a position as Commerce Committee administrator.

Stalboerger currently serves on the Health Policy Committee for the Minnesota Chamber of Commerce and is a planning committee member of the chamber's Leadership Minnesota program. He also chairs the Dakota County Regional Chamber of Commerce; serves on the Board of Directors for the Community Action Council in Lakeville, Minnesota; and is a member of the Politics and Policy Alumni Chapter at the College of Saint Benedict/Saint John's University.

A graduate of St. John's University in Collegeville, Minnesota, Stalboerger holds a Bachelor of Arts in Political Science and earned his Masters of Arts in Public Administration from Hamline University, St. Paul.

Blue Cross and Blue Shield of Minnesota, with headquarters in the St. Paul suburb of Eagan, was chartered in 1933 as Minnesota's first health plan and continues to carry out its charter mission today: to promote a wider, more economical and timely availability of health services for the people of Minnesota. A not-for-profit, taxable organization, Blue Cross is the largest health plan based in Minnesota, covering 2.9 million members in Minnesota and nationally through its health plans or plans administered by its affiliated companies. Blue Cross and Bl
'/>"/>

SOURCE Blue Cross and Blue Shield of Minnesota
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. President Bush Declares March as Red Cross Month
2. Breast cancer death rates among black women not decreasing across all states
3. Celebrities Join the American Red Cross in 2008 to Help Change Lives
4. Anthem Blue Cross and Blue Shields Member Health Index Named BlueWorks(R) Award Winner
5. Anthem Blue Cross and Blue Shield Teams with the State of Indiana to Combat Obesity
6. Former Blue Cross/Blue Shield Account Manager Sentenced for Health Care Fraud Scheme, Tax Evasion
7. Blue Cross of California Honored with Two BlueWorks(R) Awards
8. TexSAn Heart Hospital Signs Agreement with Blue Cross and Blue Shield of Texas
9. Blue Cross of California Responds to Recent Media Coverage of Rescission
10. FTCR: Gov. Schwarzenegger Must Follow Through on Call to Ban Blue Cross From Using Doctors as Double-Agents to Dump Sick Patients
11. eCommLink Employees Give Back to Community, Local American Red Cross
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 2015 Could genetic code determine someone’s ... study by researchers at the Harvard T.H. Chan ... support of the Coffee and Caffeine Genetics Consortium and ... past fall, the study—one of several recent HSPH investigations ... from more than 120,000 regular coffee drinkers of European ...
(Date:3/28/2015)... 2015 Thousands of transvaginal mesh ... C.R. Bard, Inc. continue to move forward in ... Southern District of West Virginia, where Bernstein Liebhard ... Plaintiffs’ Steering Committee. According to an Order ... defendants named in those lawsuits leave to amend ...
(Date:3/28/2015)... York, NY (PRWEB) March 28, 2015 ... highlighted a problem which could prove critical to organizations ... system testing, a critical aspect of data security, is ... card industry data security report, every major category out ... scanning and penetration testing. “With all the craziness that ...
(Date:3/28/2015)... 2015 How best to treat and ... in orthopaedic medicine. While diagnostic hip injections are commonly ... pain etiology, research presented today at the American Orthopaedic ... suggests that pain relief from this diagnostic injection may ... , “Our study looked to assess if the amount ...
(Date:3/28/2015)... March 28, 2015 Andrew Hawley of Vintage ... Who psychedelic concert posters. The Who and the Doors played ... August 2, 1968. According to Hawley, “The Who toured the ... halls and college campuses. Perhaps the most famous Who poster ... Morrison and the Doors on August 2, 1968 at the ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2
... Age should not be a factor in determining ... shown that older heart transplant patients do just as ... evaluated all 275 adult patients who received a heart ... and 2000. The patients' mortality and morbidity rates were ...
... and people without liver cancer found that diabetics are stand ... the general population.// ,After taking other factors into account, ... researchers found diabetes nearly tripled the risk of liver cancer. ... for liver cancer, may be boosting the risk even further. ...
... cause skin cancer – melanoma ,however researchers as the number ... number of patients surviving the disease. // Two new studies ... kinds of cancer. In a study conducted by researchers on ... it was discovered that melanoma patients with higher levels of ...
... The most deadly form of skin cancer , advanced ... with tumor proteins, say researchers according to a recent ... with tumor antigens (called MAGE-3) might have on patients’ ... was found that injecting patients with the tumor antigens ...
... a recent study researchers focused on the use ... their impact on cholesterol and C-reactive protein levels. ... the liver that predicts inflammation in the arteries. ... important key to determining cardiovascular risk.,Researchers focused on ...
... the heart's own can, such as raising the heart rate ... a hill but researchers say a pacemaker created by // ... have shown that genetically engineered heart cells from human embryonic ... according to a new study. Researchers injected clusters of human ...
Cached Medicine News:
(Date:3/27/2015)... 2015  Holographic Optical Technologies of Augusta, ... medical imaging, is entering the world of consumer electronics ... April 20 th , 2015, the campaign will introduce ... and 22-inch displays will allow consumers to view fully ... In addition to the two displays, the company will ...
(Date:3/27/2015)... , March 27, 2015 The Temple Health ... April to a 5,000-square-foot building at 1802 South First St. ... area designated by the City of Temple ... & White and the Central Texas Veterans Health Care System, ... laboratory space to early stage biotechnology and life science companies. ...
(Date:3/27/2015)... LAS VEGAS , March 27, 2015 Zimmer Holdings, Inc. ... its NexGen ® Complete Knee System. ... 2015 is the 20 th year since Zimmer first introduced the ... to the market. To date, more than five million implantations of the ... 20 year history of the NexGen knee demonstrates the importance ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2
... Dehaier Medical Systems Ltd. (Nasdaq: ... in the development, assembly, marketing and sale of medical ... that it will release financial results for the third ... Monday, November 14, 2011 before the start of trading ...
... UCB today announced findings from a post-hoc analysis suggesting ... (certolizumab pegol) plus methotrexate (MTX) as early as Week ... in patients with moderate to severe rheumatoid arthritis (RA) ... RAPID3 (Routine Assessment of Patient Index Data 3) and ...
Cached Medicine Technology:Dehaier Medical to Report Third Quarter 2011 Financial Results on November 14 2New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 2New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 3New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 4New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 5New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 6New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 7New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 8New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 9New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 10New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 11New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 12
... Plus Retics is a 5-part differential control ... the Abbott CELL-DYN 3200, 3500, 3700 and ... contains nucleated red blood cells that can ... 4000. The assay contains automated and manual ...
... Sickle-Chex is a positive and negative whole ... of Hemoglobin S in solubility tests and ... SICKLEDEX and other manufacturers' solubility kits. ... squeeze dropper vial. The vial dispenses an ...
... blood hematology control manufactured specifically for the ... the Coulter AcT5diff instruments. The composition of ... differential, positioning the populations within the limitations ... product offers 105-day closed-vial stability and 14-day ...
... STaK-Chex, a whole blood assayed hematology ... five-part white cell differential available with the ... unique product has 14-day open-vial stability, 105-day ... normal and high levels. The 4.0ml pierceable ...
Medicine Products: